首页 | 本学科首页   官方微博 | 高级检索  
     


Limited duration of antiarrhythmic drug use for newly diagnosed atrial fibrillation in a nationwide population under age 65
Authors:Robert N. D'Angelo MD  MS  Motiur Rahman MPS  PhD  Rahul Khanna MBA  PhD  Robert W. Yeh MD  MSc  Laura Goldstein MPH  Sashi Yadalam PhD  Iftekhar Kalsekar PhD  Patricia Tung  Peter J. Zimetbaum MD
Affiliation:1. Richard A. and Susan F. Smith Center for Outcomes Research, Division of Cardiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA;2. Medical Device Epidemiology and Real World Data Science, Johnson and Johnson, New Brunswick, New Jersey, USA;3. Franchise Health Economics and Market Access, Johnson and Johnson, Irvine, California, USA;4. Medical Device Epidemiology and Real World Data Science, Johnson and Johnson, New Brunswick, New Jersey, USA

Medical Safety, Johnson and Johnson, New Brunswick, New Jersey, USA

Abstract:
Keywords:antiarrhythmic drugs  atrial fibrillation  catheter ablation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号